HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Non-medical Switching of Infliximab to CT-P13 Biosimilar in Inflammatory Bowel Disease: A Focus on the Definition of "Non-medical Switch".

AuthorsAngelo Viscido, Giovanni Latella
JournalDigestive diseases and sciences (Dig Dis Sci) Vol. 65 Issue 9 Pg. 2737-2738 (09 2020) ISSN: 1573-2568 [Electronic] United States
PMID32591967 (Publication Type: Letter, Comment)
Chemical References
  • Antibodies, Monoclonal
  • Biosimilar Pharmaceuticals
  • CT-P13
  • Infliximab
Topics
  • Antibodies, Monoclonal
  • Biosimilar Pharmaceuticals
  • Humans
  • Inflammatory Bowel Diseases (drug therapy)
  • Infliximab (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: